(Q46903090)

26 December 2017

title

Inhibition of amyloid fibrillization of hen egg-white lysozymes by rifampicin and p-benzoquinone (English)

1 reference

26 December 2017

0 references

1 reference

Valerie H Lieu

1

1 reference

26 December 2017

Josephine W Wu

series ordinal

2

1 reference

26 December 2017

Steven S-S Wang

series ordinal

3

1 reference

26 December 2017

Chia-Hung Wu

series ordinal

4

1 reference

26 December 2017

publication date

11 May 2007

1 reference

26 December 2017

published in

Biotechnology Progress

1 reference

26 December 2017

volume

23

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

698-706

1 reference

26 December 2017

Conformational constraints for amyloid fibrillation: the importance of being unfolded

cites work

1 reference

Rifampicin inhibits the toxicity of pre-aggregated amyloid peptides by binding to peptide fibrils and preventing amyloid-cell interaction

21 January 2018

1 reference

Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger.

21 January 2018

1 reference

Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation

21 January 2018

1 reference

Apomyoglobin folding intermediates characterized by the hydrophobic fluorescent probe 8-anilino-1-naphthalene sulfonate

21 January 2018

1 reference

History of the Development of Rifampin

21 January 2018

1 reference

Principles of protein folding, misfolding and aggregation

21 January 2018

1 reference

7 January 2021

Nativelike secondary structure in interleukin-1 beta inclusion bodies by attenuated total reflectance FTIR.

1 reference

7 January 2021

Conformational changes and disease--serpins, prions and Alzheimer's.

1 reference

7 January 2021

Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease

1 reference

7 January 2021

Alzheimer's and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches

1 reference

7 January 2021

The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid

1 reference

7 January 2021

Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces

1 reference

7 January 2021

The preaggregated state of an amyloidogenic protein: hydrostatic pressure converts native transthyretin into the amyloidogenic state

1 reference

7 January 2021

Mechanism of insulin aggregation and stabilization in agitated aqueous solutions

1 reference

7 January 2021

Molecular crowding accelerates fibrillization of alpha-synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson's disease?

1 reference

7 January 2021

Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments

1 reference

7 January 2021

Prediction of amyloid fibril-forming proteins.

1 reference

7 January 2021

High-resolution structure (1.33 A) of a HEW lysozyme tetragonal crystal grown in the APCF apparatus. Data and structural comparison with a crystal grown under microgravity from SpaceHab-01 mission

1 reference

7 January 2021

Formation of amyloid fibrils from fully reduced hen egg white lysozyme

1 reference

7 January 2021

A highly amyloidogenic region of hen lysozyme

1 reference

7 January 2021

Effects of salt concentration on association of the amyloid protofilaments of hen egg white lysozyme studied by time-resolved neutron scattering

1 reference

7 January 2021

Disrupting beta-amyloid aggregation for Alzheimer disease treatment

1 reference

7 January 2021

Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism

1 reference

7 January 2021

Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils

1 reference

7 January 2021

Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution

1 reference

7 January 2021

Requirements for generating sigmoidal time-course aggregation in nucleation-dependent polymerization model.

1 reference

7 January 2021

Stretched exponential relaxation in molecular and electronic glasses

1 reference

7 January 2021

Nonlinear kinetics and new approaches to complex reaction mechanisms.

1 reference

7 January 2021

Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins

1 reference

7 January 2021

Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism

1 reference

7 January 2021

Study of the "molten globule" intermediate state in protein folding by a hydrophobic fluorescent probe

1 reference

7 January 2021

Two distinct intermediates of trigger factor are populated during guanidine denaturation

1 reference

7 January 2021

The binding of bis-ANS to the isolated GroEL apical domain fragment induces the formation of a folding intermediate with increased hydrophobic surface not observed in tetradecameric GroEL.

1 reference

7 January 2021

Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).

1 reference

7 January 2021

Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts).

1 reference

7 January 2021

Alternative conformations of amyloidogenic proteins govern their behavior

1 reference

7 January 2021

The role of G protein activation in the toxicity of amyloidogenic Abeta-(1-40), Abeta-(25-35), and bovine calcitonin

1 reference

7 January 2021

The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology.

1 reference

7 January 2021

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

1 reference

7 January 2021

Congo red protects against toxicity of beta-amyloid peptides on rat hippocampal neurones

1 reference

7 January 2021

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

7 January 2021

Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells.

1 reference

7 January 2021

Hsp20, a novel alpha-crystallin, prevents Abeta fibril formation and toxicity.

1 reference

7 January 2021

Inadvertent intrathecal administration of rifampicin

1 reference

7 January 2021

Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro.

1 reference

7 January 2021

Inhibition of alpha-synuclein fibrillization by dopamine analogs via reaction with the amino groups of alpha-synuclein. Implication for dopaminergic neurodegeneration

1 reference

7 January 2021

Identifiers

DOI

10.1021/BP060353N

1 reference

26 December 2017

1 reference

26 December 2017